Causaly
Causaly provides an agentic AI platform for life sciences that combines knowledge graphs and workflow automation to accelerate research and development.
Causaly has raised €73M across 4 funding rounds from 9 investors, most recently a Series B round in Jul 2023. Based in London, UK; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€73M
€72,707,398
Funding rounds
4
Investors
9
distinct backers
Active since
2018-03
latest 2023-07
Funding by year
EUR raised per yearCausaly — funding by year — interactive chart.
Data table
| Causaly — funding by year | |
|---|---|
| 2018 | €819k |
| 2019 | €4.3M |
| 2021 | €14M |
| 2023 | €54M |
Signals
High confidenceRaise-next likelihood11
base rate 48% for Series B
- ▼ Past typical raise window
- ▲ Up-round momentum
Exit likelihood13
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 4 rounds raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-07-13 | Series B | €54M | Alex Gorsky,EBRD Venture Capital,Iconiq Growth,Index Ventures,Marathon Venture Capital,Olivier Pomel+1 more | View deal → |
| 2021-05-20 | Series A | €14M | EBRD Venture Capital,Index Ventures,Marathon Venture Capital,Pentech Ventures | View deal → |
| 2019-10-01 | Series A | €4.3M | Pentech Ventures | View deal → |
| 2018-03-01 | Seed | €819k | Marathon Venture Capital | View deal → |